The National Institute of Diabetes & Digestive & Kidney Disease

Type 1 Diabetes Research

What is the Special Statutory Funding Program for Type 1 Diabetes Research?

The Special Statutory Funding Program for Type 1 Diabetes Research is a special appropriation that the NIDDK administers on behalf of the Secretary of the Department of Health and Human Services, in collaboration with multiple NIH Institutes and Centers and the CDC, for research on the prevention and cure of type 1 diabetes in the amount of $1.59 billion for Fiscal Year (FY) 1998 through FY 2011.

Special funding for type 1 diabetes research was initially provided by the Balanced Budget Act of 1997, Public Law (P.L.) 105-33 (now Section 330B of the Public Health Service Act). This funding was later extended and augmented by Section 931 of the 2001 Consolidated Appropriations Act (P.L. 106-554), the Public Health Service Act Amendment for Diabetes (P.L.107-360), the Medicare, Medicaid, and SCHIP Extension Act of 2007 (P.L. 110-173), and the Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110-275). The Table below summarizes the program's funding levels since its inception in 1998. This funding program supplements regularly appropriated funds that the NIH receives for diabetes research.

The Special Funding Program has enabled the creation of unique, innovative, and collaborative research consortia and clinical trials networks focused on the prevention, treatment, and cure of type 1 diabetes. These consortia have generated numerous research resources for use by the broad scientific community. Please also see current and upcoming funding opportunities.